Human cytomegalovirus (HCMV) is a widespread pathogen that is the leading viral cause of birth defects and a major cause of morbidity and mortality in adults who are immunocompromised. It is a life-threatening, opportunistic infection in AIDS and a common post-transplant complication in allograft recipients. HCMV has profound effects on its host cell, deregulating cell cycle progression and modulating the expression of a large number of cellular genes. HCMV also inhibits the recognition of the infected cell by the infected host. The long-term goal of this research program is to elucidate at the molecular level the function of HCMV genes that regulate the interaction of the virus with its host and thereby control the processes of viral replication and pathogenesis. This proposal is focused on the function of four HCMV immediate proteins (pIRS1, pIRS1.5, pTRS1 and IE2) and five HCMV-coded RNAs (UL21.5,UL106-109, TRS2-4, 7, 13) that are packaged in virus particles. Each of these virus products is available during the initial stage of the viral replication cycle and has the potential to regulate the virus-host interaction. Mutant viruses will be constructed lacking the coding regions for these genes, their phenotypes will be characterized, the biochemical basis for the activities of these proteins will be explored, and the mechanism by which RNAs are directed to be packaged in the virion will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA085786-05
Application #
6745616
Study Section
Virology Study Section (VR)
Program Officer
Daschner, Phillip J
Project Start
2000-04-01
Project End
2006-02-14
Budget Start
2004-06-15
Budget End
2006-02-14
Support Year
5
Fiscal Year
2004
Total Cost
$310,032
Indirect Cost
Name
Princeton University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
08544
Teng, Melissa W; Bolovan-Fritts, Cynthia; Dar, Roy D et al. (2012) An endogenous accelerator for viral gene expression confers a fitness advantage. Cell 151:1569-80
Cristea, Ileana M; Moorman, Nathaniel J; Terhune, Scott S et al. (2010) Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol 84:7803-14
Terhune, Scott S; Moorman, Nathaniel J; Cristea, Ileana M et al. (2010) Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. PLoS Pathog 6:e1000965
Womack, Andrew; Shenk, Thomas (2010) Human cytomegalovirus tegument protein pUL71 is required for efficient virion egress. MBio 1:
Hargett, Danna; Shenk, Thomas E (2010) Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci U S A 107:20039-44
Aoyagi, Mariko; Gaspar, Miguel; Shenk, Thomas E (2010) Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1. Proc Natl Acad Sci U S A 107:2640-5
Moorman, Nathaniel J; Shenk, Thomas (2010) Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication. J Virol 84:5260-9
Moorman, Nathaniel J; Sharon-Friling, Ronit; Shenk, Thomas et al. (2010) A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation. Mol Cell Proteomics 9:851-60
Mitchell, Dora P; Savaryn, John P; Moorman, Nathaniel J et al. (2009) Human cytomegalovirus UL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs. J Virol 83:10187-97
Schroer, Jorg; Shenk, Thomas (2008) Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A 105:19468-73

Showing the most recent 10 out of 38 publications